Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure
Public ClinicalTrials.gov record NCT02365818. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Single Arm, Phase II, Multicenter Study of the Safety and Efficacy of CG0070 Oncolytic Vector Regimen in Patients With Non-Muscle Invasive Bladder Carcinoma Who Have Failed BCG (Bacillus Calmette-Guerin) Therapy and Refused Cystectomy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To study the safety and efficacy of CG0070, an oncolytic virus expression GM-CSF in high grade non muscle invasive bladder cancer patients who failed BCG therapy and refused cystectomy.
Study identification
- NCT ID
- NCT02365818
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 66 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 1, 2015
- Primary completion
- Jul 31, 2018
- Completion
- Jan 31, 2019
- Last update posted
- Apr 13, 2021
2015 – 2019
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Clinical Research Center | Anchorage | Alaska | 99503 | — |
| BCG Oncology | Phoenix | Arizona | 85032 | — |
| Arizona Institute of Urology | Tucson | Arizona | 85704 | — |
| Institute of Urologic Oncology at UCLA | Los Angeles | California | 90095 | — |
| UC Irvine Medical Center | Orange | California | 92868 | — |
| University of California, San Diego | San Diego | California | 92093 | — |
| UF Health Cancer Center | Gainesville | Florida | 32610 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Michigan Institute of Urology, P.C. | Troy | Michigan | 48084 | — |
| Adult Pediatric Urology and Urogynecology, PC | Omaha | Nebraska | 68114 | — |
| GU Research Network/ The Urology Center | Omaha | Nebraska | 68130 | — |
| Premier Urology Group, LLC. | Edison | New Jersey | 08837 | — |
| Premier Medical Group of the Hudson Valley | Poughkeepsie | New York | 12061 | — |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | 27157 | — |
| The Urology Group | Cincinnati | Ohio | 45212 | — |
| Vanderbilt University Medical Center, Dept. of Urologic Surgery | Nashville | Tennessee | 37232 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02365818, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2021 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02365818 live on ClinicalTrials.gov.